About Dr. Elizabeth Yu Chiao

Dr. Chiao is a Professor in the Department of Epidemiology and has a joint appointment in the Department of General Oncology. She is board certified in both Medical Oncology and Infectious Diseases and she primarily treats patients with virally mediated cancers, and cancers in people with HIV (PWH) such as Kaposi Sarcoma and HPV-related pre-cancers. She completed her medical education at the Weil Cornell Medical School, her post graduate residency at the University of Utah, her Medical Oncology training at Memorial Sloan Kettering Cancer Center, and her Infectious Disease fellowship at the Baylor College of Medicine. She is the chair of the Solid Tumor Working Group in the AIDS Malignancy (AMC), an NCI funded clinical trials consortium focused on providing access to clinical trials for PWH, and is a member of the Board of Scientific Advisors HIV and AIDs Malignancies subcommittee for the NCI. In addition to her cancer prevention and treatment clinical trials research, she is the principal investigator of several NIH funded projects on the epidemiology, and outcomes of virally mediated cancers and HIV-related cancers, which focuses on research utilizing large clinical databases and the development of clinical cohorts to help improve clinical outcomes and decrease cancer outcome disparities for PWH and cancer in low-income and marginalized communities. Dr. Chiao is also a principal investigator on NIH funded projects focused on improving screening for squamous HPV-related cancers for PWH and a co-investigator on projects to improve cancer screening, treatment and outcomes for HPV and other virally mediated cancers.